ALLIANCEBERNSTEIN L.P. - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 50 filers reported holding OVID THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$36,829
-83.7%
47,880
-14.7%
0.00%
Q1 2021$226,000
+73.8%
56,1000.0%0.00%
Q4 2020$130,000
-59.6%
56,1000.0%0.00%
Q3 2020$322,000
-22.0%
56,1000.0%0.00%
Q2 2020$413,000
+516.4%
56,100
+377.6%
0.00%
Q3 2018$67,00011,7460.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$4,32918.57%
Madison Avenue Partners, LP 3,307,605$10,848,9432.37%
CHI Advisors LLC 864,822$2,836,6160.86%
Rubric Capital Management LP 5,445,910$17,862,5850.76%
BVF INC/IL 6,851,051$22,471,4470.63%
EcoR1 Capital, LLC 6,117,400$20,065,0720.49%
Artal Group S.A. 2,500,000$8,2000.25%
Tejara Capital Ltd 112,591$369,2980.18%
DCF Advisers, LLC 64,764$212,4260.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 801,152$2,627,7790.06%
View complete list of OVID THERAPEUTICS INC shareholders